enGene Therapeutics Statistics

Total Valuation

ENGN has a market cap or net worth of $466.25 million. The enterprise value is $225.10 million.

Market Cap	466.25M
Enterprise Value	225.10M

Important Dates

The next estimated earnings date is Thursday, June 11, 2026, before market open.

Earnings Date	Jun 11, 2026
Ex-Dividend Date	n/a

Share Statistics

ENGN has 66.99 million shares outstanding. The number of shares has increased by 23.40% in one year.

Current Share Class	66.99M
Shares Outstanding	66.99M
Shares Change (YoY)	+23.40%
Shares Change (QoQ)	+30.91%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	42.26%
Float	26.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.75, with a Debt / Equity ratio of 0.12.

Current Ratio	11.75
Quick Ratio	11.36
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.95

Financial Efficiency

Return on equity (ROE) is -46.07% and return on invested capital (ROIC) is -27.06%.

Return on Equity (ROE)	-46.07%
Return on Assets (ROA)	-25.63%
Return on Invested Capital (ROIC)	-27.06%
Return on Capital Employed (ROCE)	-40.88%
Weighted Average Cost of Capital (WACC)	4.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.49M
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-18,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.92% in the last 52 weeks. The beta is -0.05, so ENGN's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+78.92%
50-Day Moving Average	8.02
200-Day Moving Average	7.31
Relative Strength Index (RSI)	38.36
Average Volume (20 Days)	379,742

Short Selling Information

The latest short interest is 1.33 million, so 1.99% of the outstanding shares have been sold short.

Short Interest	1.33M
Short Previous Month	1.15M
Short % of Shares Out	1.99%
Short % of Float	5.03%
Short Ratio (days to cover)	5.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-127.74M
Pretax Income	-122.46M
Net Income	-122.44M
EBITDA	-127.14M
EBIT	-127.74M
Earnings Per Share (EPS)	-$2.22

Full Income Statement

Balance Sheet

The company has $275.95 million in cash and $33.46 million in debt, giving a net cash position of $242.48 million or $3.62 per share.

Cash & Cash Equivalents	275.95M
Total Debt	33.46M
Net Cash	242.48M
Net Cash Per Share	$3.62
Equity (Book Value)	281.55M
Book Value Per Share	4.20
Working Capital	264.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$102.45 million and capital expenditures -$1.34 million, giving a free cash flow of -$103.79 million.

Operating Cash Flow	-102.45M
Capital Expenditures	-1.34M
Depreciation & Amortization	596,000
Net Borrowing	1.25M
Free Cash Flow	-103.79M
FCF Per Share	-$1.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.40%
Shareholder Yield	-23.40%
Earnings Yield	-26.19%
FCF Yield	-22.20%

Analyst Forecast

The average price target for ENGN is $21.08, which is 202.87% higher than the current price. The consensus rating is "Buy".

Price Target	$21.08
Price Target Difference	202.87%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1